Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Teva
Deloitte
Argus Health
McKinsey
Mallinckrodt
Accenture
QuintilesIMS

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017571

« Back to Dashboard

NDA 017571 describes ALUPENT, which is a drug marketed by Boehringer Ingelheim and is included in five NDAs. Additional details are available on the ALUPENT profile page.

The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.
Summary for 017571
Tradename:ALUPENT
Applicant:Boehringer Ingelheim
Ingredient:metaproterenol sulfate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength10MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Federal Trade Commission
US Department of Justice
Moodys
Deloitte
Queensland Health
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.